Brioli A; Parisi S; Iacobucci I; Cavo M; Papayannidis C; Anna Zannetti B; Martinelli G; Baccarani M., Patient with ataxia telangiectasia who developed acute myeloid leukemia., «LEUKEMIA & LYMPHOMA», 2011, 52(9), pp. 1818 - 1820 [Scientific article]
PARISI S; PAOLINI S; IACOBUCCI I; PAPAYANNIDIS C; ABBENANTE M; CURTI A; OTTAVIANI E; TESTONI N; BACCARANI M; MARTINELLI G, Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience, in: Blood, «BLOOD», 2011, 118, pp. 4261 - 4261 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [Abstract]
Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Cristina Papayannidis, Mariachiara Abbenante, Antonio Curti, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli, Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience, «BLOOD», 2011, 118, pp. 4261 - 4261 [Abstract]
Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli, PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients, «BLOOD», 2011, 118, pp. 1429 - 1429 [Abstract]
I Iacobucci ;A Lonetti ;A Candoni ;M Sazzini ;S Formica ;E Ottaviani ;A Ferrari ;C Papayannidis ;A Michelutti ;E Toffoletti ;A Astolfi ;S Paolini ;MC Abbenante ;S Parisi ;F Cattina ;D Russo ;D Damiani ;F Gherlinzoni ;E Gottardi ;M Baccarani ;R Fanin ;G Martinelli, PHARMACOGENOMIC PROFILE ASSOCIATED WITH HIGH SENSITIVITY AND LOW TOXICITY TO A COMBINATION OF GEMTUZUMAB OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN IN CD33-POSITIVE ACUTE MYELOID LEUKEMIA, in: S2, «HAEMATOLOGICA», 2011, 96, pp. 85 - 85 (atti di: 16th Congress of European Hematology Association, London, United Kingdom, June 9-12, 2011) [Abstract]
Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Michele Baccarani, Hagop M. Kantarjian, Cristina Papayannidis, Kristen N. Rice, Xiaoxi Zhang, Naveed Shaik, Rachel Courtney, Wendy J. Levin, Giovanni Martinelli, Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies, «BLOOD», 2011, 118, pp. 424 - 424 [Abstract]
Soverini S; Vitale A; Poerio A; Gnani A; Colarossi S; Iacobucci I; Cimino G; Elia L; Lonetti A; Vignetti M; Paolini S; Meloni G; di Maio V; Papayannidis C; Amabile M; Guarini A; Baccarani M; Martinelli G; Foa' R, Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis, «HAEMATOLOGICA», 2011, 96, pp. 552 - 557 [Scientific article]
C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini;
C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi;
G Martinelli; L Cocco; M Baccarani, PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE
AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK
MYELODYSPLASTIC SYNDROMES, in: Abstract Book, «HAEMATOLOGICA», 2011, 96, pp. 348 - 348 (atti di: 16th Congress of the European Hematology Association, LONDON, June 9–12, 2011) [Abstract]
C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani, Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response, in: Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS), «LEUKEMIA RESEARCH», 2011, 35, pp. S65 - S65 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Abstract]
Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Brighenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli, The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL), «BLOOD», 2011, 118, Article number: 76 , pp. 76 - 76 [Abstract]
Iacobucci, I.; Ferrari, A.; Lonetti, A.; Papayannidis, C.; Paoloni, F.; Abbenante, M.; Guadagnuolo, V.; Ottaviani, E.; Cattina, F.; Vitale, A.; Paolini, S.; Soverini, S.; Parisi, S.; Vignetti, M.; Baccarani, M.; Martinelli, G., The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL), in: J Clin Oncol 29: 2011 (suppl; abstr 6532), «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 6532 - 6532 (atti di: 47th ASCO Annual Meeting, Chicago, Illinois., June 3-7, 2011) [Abstract]
A Ferrari ;I Iacobucci ;M Sazzini ;A Lonetti ;A Boattini ;C Papayannidis ;P Garagnani ;MC Abbenante ;V Mantovani ;F Cattina ;E Marasco ;E Ottaviani ;S Paolini ;D Girelli ;M Vignetti ;F Pane ;S Soverini ;M Baccarani ;G Martinelli, THE RS564398, A POLYMORPHISM IN “THE ANTISENSE NON-CODING RNA IN THE INK4 LOCUS”, ANRIL, IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) SUSCEPTIBILITY, in: S2, «HAEMATOLOGICA», 2011, 96, pp. 2 - 3 (atti di: 16th Congress of European Hematology Association, London, United Kingdom, June 9-12, 2011) [Abstract]
Ilaria Iacobucci, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, Giovanni Martinelli, TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia, «BLOOD», 2011, 118 (21), Article number: 1484 , pp. 1484 - 1484 [Abstract]
Soverini S; De Benedittis C; Gnani A; Iacobucci I; Russo D; Cattina F; Castagnetti F; Gugliotta G; Papayannidis C; Vitale A; Elia L; Foà R; Palandri F; Lonetti A; Bochicchio MT; Durante S; Rosti G; Baccarani M; Martinelli G, Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients, in: vol. 118 no. 21 3775, «BLOOD», 2011, 118 (21), pp. 3775 - 3775 (atti di: 53^ American Society of Hematology Annual Meeting and Exposition, San Diego, California, 9-13 Dicembre 2011) [Abstract]
Lonetti A; Iacobucci I; Ferrari A; Papayannidis C; Paolini S; Cilloni D; Abbenante M; Guadagnuolo V; Pane F; Baccarani M; Martinelli G, A HIGH SENSITIVE NANOFLUIDIC ARRAY IMPROVES THE DETECTION OF RARE COPIES OF BCR-ABL1 TRANSCRIPT IN PATIENTS WITH PHILADELPHIA POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), in: S3, «HAEMATOLOGICA», 2010, 95, pp. S29 - S29 (atti di: XI Congresso Nazionale SIES, Turin, Italy, October 06–08, 2010) [Abstract]
